Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 158,171 | 70,156 | 89,599 | 125,390 | 87,250 |
| Marketable Securities | 234,858 | 247,636 | 240,106 | 195,825 | 164,555 |
| Receivables | 35,852 | 34,216 | 281 | N/A | N/A |
| TOTAL | $436,981 | $358,356 | $333,938 | $332,389 | $255,053 |
| Non-Current Assets | |||||
| PPE Net | 3,714 | 3,617 | 3,364 | 2,934 | 2,904 |
| Other Non-Current Assets | 2,018 | 2,274 | 1,287 | 1,499 | 1,299 |
| TOTAL | $5,732 | $5,891 | $4,651 | $4,433 | $4,203 |
| Total Assets | $442,713 | $364,247 | $338,589 | $336,822 | $259,256 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,880 | 6,998 | 8,705 | 10,212 | 15,083 |
| Accrued Expenses | 54,947 | 52,441 | 21,427 | 28,851 | 34,272 |
| Other current liabilities | N/A | N/A | 194 | 182 | N/A |
| TOTAL | $151,419 | $141,106 | $151,357 | $181,591 | $133,463 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 78,592 | 81,667 | 121,031 | 142,346 | 84,108 |
| Other Non-Current Liabilities | 21 | 22 | 23 | 24 | 26 |
| TOTAL | $94,197 | $100,567 | $87,357 | $98,233 | $95,176 |
| Total Liabilities | $245,616 | $241,673 | $238,714 | $279,824 | $228,639 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,883 | 48,346 | 47,269 | 47,151 | 38,863 |
| Common Shares | 1 | N/A | N/A | N/A | N/A |
| Retained earnings | -394,225 | -370,807 | -386,330 | -363,196 | -341,679 |
| Other shareholders' equity | -550 | -442 | -181 | -254 | -179 |
| TOTAL | $197,097 | $122,574 | $99,875 | $56,998 | $30,617 |
| Total Liabilities And Equity | $442,713 | $364,247 | $338,589 | $336,822 | $259,256 |